# 68Ga-P16-093 and 18F-FDG PET/CT Imaging in the Same Group of Clear Cell Renal Cell Carcinoma Patients

> **NCT05432947** · NA · COMPLETED · sponsor: **Peking Union Medical College Hospital** · enrollment: 42 (actual)

## Conditions studied

- Clear Cell Renal Cell Carcinoma

## Interventions

- **DRUG:** 68Ga-P16-093
- **DRUG:** 18F-FDG

## Key facts

- **NCT ID:** NCT05432947
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-14
- **Primary completion:** 2022-09-04
- **Final completion:** 2022-09-15
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2022-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05432947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05432947, "68Ga-P16-093 and 18F-FDG PET/CT Imaging in the Same Group of Clear Cell Renal Cell Carcinoma Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05432947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*